Biotech Values

[mcbio]

Anyone know of any company that had less than 12 months of cash on hand that got a good deal for a ph ii compound - (e.g. >15% royalties plus partner covers all trial costs)?

I'll submit ARRY on two occasions, once for the deal with NVS on MEK162 (http://investor.arraybiopharma.com/phoenix.zhtml?c=123810&p=irol-newsArticle&ID=1414590&highlight= ) and also with AMGN on ARRY-403 (http://investor.arraybiopharma.com/phoenix.zhtml?c=123810&p=irol-newsArticle&ID=1365735&highlight= ). And actually, both of those drugs were in Phase 1 at the time of those deals. I don't think ARRY had more than 12 months of cash at the time of those deals and, if they did, it wasn't much more.